Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ceapro appoints Ulrich Kosciessa to board

This article was originally published in Scrip

Executive Summary

Ceapro, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, has appointed international pharmaceutical industry expert Dr Ulrich Kosciessa to its board of directors. Dr Kosciessa has over two decades of research, business development and marketing leadership experience. He is a member of the executive management board of Medac, a global pharmaceutical company with operations in 70 countries, managing director of Medac, and chair of the board of Medac Pharma, a US-based subsidiary of Medac focused on specialty pharmaceuticals for autoimmune diseases and cancer. 


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts